|
Maryland
|
1-13648
|
13-2578432
|
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification No.)
|
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
|
Common Stock, par value $.06-2/3 per share
|
BCPC
|
The Nasdaq Stock Market LLC
|
| Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
|
| Item 9.01 |
Financial Statements and Exhibits.
|
|
Exhibit Number
|
Description
|
|
104
|
Cover Page Interactive Data File (embedded within the Inline XBRL document)
|
|
BALCHEM CORPORATION
|
|||
|
(Registrant)
|
|||
|
By:
|
/s/ Hatsuki Miyata
|
||
|
Hatsuki Miyata
|
|||
|
Executive Vice President, Chief Legal Officer and Secretary
|
|||
|
Date: March 3, 2025
|
|||